129 related articles for article (PubMed ID: 33654885)
1. Assessment of Humoral Alloimmunity in Mixed Lymphocyte Reaction.
Pissas G; Eleftheriadis T
Bio Protoc; 2019 Jan; 9(2):e3139. PubMed ID: 33654885
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis between proteasome and immunoproteasome inhibition in cellular and humoral alloimmunity.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Int Immunopharmacol; 2017 Sep; 50():48-54. PubMed ID: 28628770
[TBL] [Abstract][Full Text] [Related]
3. In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity.
Eleftheriadis T; Pissas G; Sounidaki M; Antoniadi G; Antoniadis N; Liakopoulos V; Stefanidis I
Int Urol Nephrol; 2017 Sep; 49(9):1691-1697. PubMed ID: 28508247
[TBL] [Abstract][Full Text] [Related]
4. Uric acid increases cellular and humoral alloimmunity in primary human peripheral blood mononuclear cells.
Eleftheriadis T; Pissas G; Sounidaki M; Antoniadi G; Antoniadis N; Liakopoulos V; Stefanidis I
Nephrology (Carlton); 2018 Jul; 23(7):610-615. PubMed ID: 28477373
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity.
Eleftheriadis T; Pissas G; Mavropoulos A; Liakopoulos V; Stefanidis I
Biomed Rep; 2017 Nov; 7(5):439-444. PubMed ID: 29181155
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase suppresses humoral alloimmunity via pathways that different to those associated with its effects on T cells.
Sounidaki M; Pissas G; Eleftheriadis T; Antoniadi G; Golfinopoulos S; Liakopoulos V; Stefanidis I
Biomed Rep; 2019 Jun; 1(1):1-5. PubMed ID: 31258898
[TBL] [Abstract][Full Text] [Related]
7. In Mixed Lymphocyte Reaction, the Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat Suppresses Cellular and Humoral Alloimmunity.
Eleftheriadis T; Pissas G; Mavropoulos A; Nikolaou E; Filippidis G; Liakopoulos V; Stefanidis I
Arch Immunol Ther Exp (Warsz); 2020 Oct; 68(6):31. PubMed ID: 33011826
[TBL] [Abstract][Full Text] [Related]
8. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
Front Immunol; 2018; 9():3039. PubMed ID: 30740108
[TBL] [Abstract][Full Text] [Related]
9. Tocilizumab (Anti-IL-6R) Suppressed TNFα Production by Human Monocytes in an In Vitro Model of Anti-HLA Antibody-Induced Antibody-Dependent Cellular Cytotoxicity.
Shin BH; Ge S; Mirocha J; Jordan SC; Toyoda M
Transplant Direct; 2017 Mar; 3(3):e139. PubMed ID: 28361123
[TBL] [Abstract][Full Text] [Related]
10. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
[TBL] [Abstract][Full Text] [Related]
11. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
[TBL] [Abstract][Full Text] [Related]
12. Whole blood assay for assessment of the mixed lymphocyte reaction.
Bromelow KV; Hirst W; Mendes RL; Winkley AR; Smith IE; O'Brien ME; Souberbielle BE
J Immunol Methods; 2001 Jan; 247(1-2):1-8. PubMed ID: 11150531
[TBL] [Abstract][Full Text] [Related]
13. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium.
Hosenpud JD; Everett JP; Morris TE; Mauck KA; Shipley GD; Wagner CR
Circulation; 1995 Jul; 92(2):205-11. PubMed ID: 7600652
[TBL] [Abstract][Full Text] [Related]
14. Human T lymphoblasts and activated dendritic cells in the allogeneic mixed leukocyte reaction are susceptible to NK cell-mediated anti-CD83-dependent cytotoxicity.
Munster DJ; MacDonald KP; Kato M; Hart DJ
Int Immunol; 2004 Jan; 16(1):33-42. PubMed ID: 14688058
[TBL] [Abstract][Full Text] [Related]
15. A streamlined proliferation assay using mixed lymphocytes for evaluation of human mesenchymal stem cell immunomodulation activity.
Herzig MC; Delavan CP; Jensen KJ; Cantu C; Montgomery RK; Christy BA; Cap AP; Bynum JA
J Immunol Methods; 2021 Jan; 488():112915. PubMed ID: 33212091
[TBL] [Abstract][Full Text] [Related]
16. Pathways of helper CD4 T cell allorecognition in generating alloantibody and CD8 T cell alloimmunity.
Taylor AL; Negus SL; Negus M; Bolton EM; Bradley JA; Pettigrew GJ
Transplantation; 2007 Apr; 83(7):931-7. PubMed ID: 17460565
[TBL] [Abstract][Full Text] [Related]
17. Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques.
Page EK; Page AJ; Kwun J; Gibby AC; Leopardi F; Jenkins JB; Strobert EA; Song M; Hennigar RA; Iwakoshi N; Knechtle SJ
Am J Transplant; 2012 Sep; 12(9):2395-405. PubMed ID: 22776408
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous alterations in human alloimmunity associated with immunization.
Roddy M; Clemente M; Poggio ED; Bukowski R; Thakkar S; Waxenecker G; Loibner H; Himmler G; Hricik DE; Heeger PS
Transplantation; 2005 Aug; 80(3):297-302. PubMed ID: 16082322
[TBL] [Abstract][Full Text] [Related]
19. Indirect allorecognition of platelets by T helper cells during platelet transfusions correlates with anti-major histocompatibility complex antibody and cytotoxic T lymphocyte formation.
Semple JW; Speck ER; Milev YP; Blanchette V; Freedman J
Blood; 1995 Jul; 86(2):805-12. PubMed ID: 7606011
[TBL] [Abstract][Full Text] [Related]
20. CTLA4-Ig prevents alloantibody production and BMT rejection in response to platelet transfusions in mice.
Gilson CR; Patel SR; Zimring JC
Transfusion; 2012 Oct; 52(10):2209-19. PubMed ID: 22321003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
